HomeCompareOPNT vs BTI

OPNT vs BTI: Dividend Comparison 2026

OPNT yields 9.69% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OPNT wins by $252.00 in total portfolio value
10 years
OPNT
OPNT
● Live price
9.69%
Share price
$20.65
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.0K
Annual income
$1,781.24
Full OPNT calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — OPNT vs BTI

📍 OPNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOPNTBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OPNT + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OPNT pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPNT
Annual income on $10K today (after 15% tax)
$823.24/yr
After 10yr DRIP, annual income (after tax)
$1,514.05/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, BTI beats the other by $854.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPNT + BTI for your $10,000?

OPNT: 50%BTI: 50%
100% BTI50/50100% OPNT
Portfolio after 10yr
$37.8K
Annual income
$2,283.94/yr
Blended yield
6.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

OPNT
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
2.9
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPNT buys
0
BTI buys
0
No recent congressional trades found for OPNT or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOPNTBTI
Forward yield9.69%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$38.0K$37.7K
Annual income after 10y$1,781.24$2,786.64
Total dividends collected$13.7K$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: OPNT vs BTI ($10,000, DRIP)

YearOPNT PortfolioOPNT Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$11,669$968.52$11,299$598.92+$370.00OPNT
2$13,542$1,056.19$12,794$703.91+$748.00OPNT
3$15,635$1,145.54$14,518$829.07+$1.1KOPNT
4$17,966$1,236.10$16,513$978.64+$1.5KOPNT
5$20,551$1,327.44$18,827$1,157.84+$1.7KOPNT
6$23,408$1,419.10$21,518$1,373.12+$1.9KOPNT
7$26,557$1,510.69$24,657$1,632.46+$1.9KOPNT
8$30,018$1,601.80$28,329$1,945.74+$1.7KOPNT
9$33,812$1,692.10$32,637$2,325.33+$1.2KOPNT
10$37,960$1,781.24$37,708$2,786.64+$252.00OPNT

OPNT vs BTI: Complete Analysis 2026

OPNTStock

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Full OPNT Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this OPNT vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPNT vs SCHDOPNT vs JEPIOPNT vs OOPNT vs KOOPNT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.